Riding on the heels of strong financials, Gujarat Themis has grown around 2.6x in the past 12 months (as of May 18, 2024).
It used to solely work as a contract manufacturer with fixed profit margins. However, its financials improved when it started selling directly to large pharma clients
Its revenue and profit margins improved significantly, and have been on a consistent rise since FY20.
Don’t rush to invest yet. D-street is ignoring some risks. Read the full article for free and uncover these risks. Click on the link below.